Evidence
How we made the decision
How we made the decision
We check our guidelines regularly to ensure they remain up to date. We based the decision on surveillance 8 years after the publication of acutely ill adults in hospital: recognising and responding to deterioration (2007) NICE guideline CG50.
For details of the process and update decisions that are available, see ensuring that published guidelines are current and accurate in 'Developing NICE guidelines: the manual'.
Previous surveillance update decisions for the guideline are on our website.
New evidence
We found 14 new studies in a search for systematic reviews and randomised controlled trials published between 01 September 2010 and 22 October 2015. We also considered 15 additional studies identified by members of the Guideline Committee who originally worked on this guideline. No further studies were identified during stakeholder consultation.
Evidence identified in previous surveillance 3 years after publication of the guideline was also considered. This included 44 studies identified by search.
From all sources, 73 studies were considered to be relevant to the guideline.
We also checked for relevant ongoing research, which will be evaluated again at the next surveillance review of the guideline.
See appendix A: decision matrix for summaries and references for all new evidence considered.
Views of topic experts
We considered the views of topic experts, including those who helped to develop the guideline and other correspondence we have received since the publication of the guideline.
Views of stakeholders
Stakeholders commented on the proposal not to update the guideline and place NICE guideline CG50 on the static list. See appendix B for stakeholders' comments and our responses. Two stakeholders agreed with the proposal not to update the guideline and another one disagreed expressing a need for NICE to endorse the use of NEWS. NICE guidelines make recommendations based on the best available evidence. New evidence and topic expert feedback suggested that there is some advancement in track and trigger assessment but more work needs to be done. In the current surveillance review none of the new evidence considered was thought to have an impact on the current recommendations.
One stakeholder agreed and another disagreed with the proposal to place NICE guideline CG50 on the static list. They mentioned that there is an updated version of NEWS in development. Given that there is ongoing research in this area which is due to be published in the near future we decided not to place NICE guideline CG50 on the static list.
See ensuring that published guidelines are current and accurate in 'Developing NICE guidelines: the manual' for more details on our consultation processes.
This page was last updated: